One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual surgery required. Today, the company announced early data from animals and ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

A research letter published in the New England Journal of Medicine calls for careful consideration of the design and consequences of health disparity incentives in future value-based payment models.

If vaccination rates continue to decline, the U.S. will have millions of measles cases over the next quarter-century and the ...

One in three dementia cases could be prevented with something as simple as treating hearing loss. As scientists present ...

Union membership among health care professionals in the United States, including physicians, is on the rise, which could have seismic implications in work patterns and patient care in an increasingly ...

The Trump administration on Thursday released what it described as a comprehensive review of gender-related medical ...

Researchers at the Department of Veterans Affairs warn that crucial medical research is in jeopardy unless the Trump ...

Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...

Medicare will cover bunion surgery, also called bunionectomy, when a doctor considers it medically necessary. A doctor may recommend bunion surgery to address significant pain or correct a ...